Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Evaxion Biotech A/S

Evaxion Biotech A/S (EVAX)

Market is closed
News
  • Displaying 5

Evaxion Biotech A/S (NASDAQ:EVAX) Q2 2024 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Evaxion Biotech Business Update Conference call. [Operator Instructions] Please be advised, that today's conference is being recorded.

Keep Reading →

August 15th, 2024 - News Transcripts

Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript

Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript

Christian Kanstrup: Hello, everyone, and a very warm welcome to this Evaxion Business Update Conference call on the back of our Full Year 2023 Results. I'm Christian Kanstrup. I'm the CEO of Evaxion.

Keep Reading →

April 3rd, 2024 - News Transcripts

Evaxion Biotech A/S (NASDAQ:EVAX) Q2 2023 Earnings Call Transcript

Evaxion Biotech A/S (NASDAQ:EVAX) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Evaxion Biotech Q2 Results Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 23rd, 2023 - News Transcripts

10 Best Immunotherapy Stocks To Buy Now

10 Best Immunotherapy Stocks To Buy Now

The global immunotherapy market is rapidly evolving as technological, regulatory, and economic trends combine to alter the growth and risk dynamics within the industry.

Keep Reading →

October 11th, 2022 - Hedge Funds News

Is Evaxion Biotech A/S (EVAX) A Good Stock To Buy?

Is Evaxion Biotech A/S (EVAX) A Good Stock To Buy?

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter.

Keep Reading →

June 15th, 2021 - Hedge Funds News

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)